Evaluation of CHA2DS2-VASc and ATRIA scores in patients with ST-elevation myocardial infarction

Abstract

Objective: CHA2DS2-VASc and ATRIA scores are a valid, practical method for the risk classification of thromboembolic complications due to atrial fibrillation. The aim of this study was to evaluate the use of CHA2DS2-VASC and ATRIA scores in predicting high-risk patients with coronary artery disease.

Patients and methods: Between May 2015 and Jan 2016, 432 patients who were followed up with a diagnosis of myocardial infarction with ST elevation were included in the study. Baseline demographic characteristics, ATRIA, CHA2DS2-VASC and SYNTAX scores were calculated. The patients were divided into two groups according to the low and medium-high SYNTAX score.

Results: 20% of the patients had moderate to high SYNTAX score and 25.9% were female. The mean age of the patients was 63.9 ± 13.7 (28-91) years. CHA2DS2-VASC score and ATRIA score were significantly higher in patients with moderate-to-high SYNTAX score than in patients with low SYNTAX score (2.0 ± 1.4 versus 2.4 ± 1.5; p = 0.014 and  3.2 ± 2.8 versus 4.2 ± 2; p = 0.009, respectively). In the correlation analysis, there was a positive correlation between the SYNTAX score and the CHA2DS2-VASC and ATRIA scores. In addition, in the single regression analysis, the CHA2DS2-VASC and ATRIA scores predicted patients with moderate to high SYNTAX scores.

Conclusion: ATRIA and CHA2DS2-VASc scores are the scoring systems that can be used in coronary artery prevalence. The use of STEMI patients in the evaluation of high-risk patients may be recommended.

Keywords

• SNTAX score,CHA2DS2-VASc score,ATRIA score,coronary artery disease

Akut Koroner Sendromu Olan Bireylerde CHA2DS2-VASc ve ATRIA Skorlarının Değerlendirilmesi

Abstract

Amaç: CHA2DS2-VASc ve ATRIA skorları atriyal fibrilasyona bağlı tromboembolik komplikasyonların risk sınıflandırmasında kullanılan geçerli, pratik bir yöntemdir. Bu çalışmada CHA2DS2-VASC ve ATRIA skorlarının koroner arter hastalığına sahip yüksek riskli hastaları ön görmedeki kullanımının değerlendirilmesi amaçlanmıştır.

Hastalar ve yöntem: Çalışmaya 2015 Mayıs ayı ile 2016 Ocak ayları arasında bir üniversite tıp fakültesi kardiyoloji ST elevasyonlu miyokart enfarktüsü tanısı ile takip edilen 432 hasta dahil edilmiştir. Tüm hastaların bazal demografik özellikleri değerlendirilmiş ATRIA, CHA2DS2-VASC ve SYNTAX skorları hesaplanmıştır. Hastalar düşük ve orta-yüksek SYNTAX skoruna göre iki gruba ayrılmıştır.

Bulgular: Hastaların %20’si orta-yüksek SYNTAX skoruna sahipti ve %25,9’u kadındı. Hastaların yaş ortalaması ise 63,9±13,7 (28-91)’di. Orta-yüksek SYNTAX skoruna sahip olan hastaların ortalama CHA2DS2-VASC(2,0±1,4 ve 2,4±1,5; p=0,014) ve ATRIA skorları (3,2±2,8 ve 4,2±2,8; p=0,009)  düşük SYNTAX grubuna sahip hastalara göre anlamlı olarak yüksekti. Yapılan korelasyon analizinde ise SYNTAX skoru ile CHA2DS2-VASC ve ATRIA skorları arasında pozitif korelasyon mevcuttu. Ayrıca yapılan tekli regresyon analizinde CHA2DS2-VASC ve ATRIA skorları orta-yüksek SYNTAX skoruna sahip hastaları öngörmekteydi.

Sonuç: ATRIA ve CHA₂DS₂-VASc skorları koroner arter yaygınlığında kullanılabilen yatak başında hızlıca değerlendirilen skorlama sistemleridir. STEMI hastalarında yüksek riskli hastaların değerlendirilmesinde kullanımı önerilebilir. 

Keywords

• SYNTAX skoru,CHA2DS2-VASc skoru,ATRIA skoru,koroner arter hastalığı

References

1. 1. Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Progress in cardiovascular diseases. 2018.
2. 2. Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nature Reviews Cardiology. 2018; 15(4): 230.
3. 3. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893-962.
4. 4. Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. Journal of the American Heart Association. 2013; 2(3): e000250.
5. 5. Aksoy F, Guler S, Kahraman F, Oskay T, Varol E. The Relation Between Echocardiographic Epicardial Fat Thickness and CHA2DS2-VASc Score in Patients with Sinus Rhythm. Brazilian journal of cardiovascular surgery. 2019; 34(1): 41-7.
6. 6. Çetinkal G, Koçaş C, Koçaş BB, Arslan Ş, Abacı O, Karaca OŞ, et al. Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction. Anatolian journal of cardiology. 2018; 20(2): 77.
7. 7. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein A-P, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5(1): 50-6.
8. 8. Cetin M, Cakici M, Zencir C, Tasolar H, Baysal E, Balli M, et al. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score. The American journal of cardiology. 2014; 113(6): 950-6.

9. 9. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European heart journal. 2017; 39(2): 119-77.
10. 10. Tang EW, Wong C-K, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. American heart journal. 2007; 153(1): 29-35.
11. 11. Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Lasica R, et al. Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score. International journal of cardiology. 2013; 162(3): 220-7.
12. 12. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European heart journal. 2016; 37(3): 267-315.